• Zishen Yutai Pills Restore Fertility in POF

  2026-09-18

  Shixuan Wang and colleagues evaluated Zishen Yutai pills in a cisplatin-induced premature ovarian failure mouse model, combining reproductive phenotyping with proteomic and metabolomic profiling. The study links improved follicle development, oocyte competence, and fertility with coordinated changes in arachidonic acid metabolism and AKT signaling.

• Chemistry of Silybin: Structure and Research Utility

  2026-09-18

  The review by Křen and colleagues establishes a chemical framework for understanding silybin, the principal flavonolignan associated with milk thistle extract. Its analysis of stereochemistry, diastereomer separation, and semisynthetic derivatives shows why compound identity and preparation method are critical when translating silymarin chemistry into biological research.

• Dlin-MC3-DMA for Tunable LNP RNA Delivery

  2026-09-17

  Dlin-MC3-DMA is an ionizable cationic liposome lipid for building RNA-loaded nanoparticles with a strong hepatic delivery track record. This workflow connects formulation design, machine-learning-guided optimization, and assay troubleshooting for siRNA delivery vehicle and mRNA vaccine formulation research.

• Tropifexor (LJN452) FXR Research Workflow

  2026-09-17

  Build reproducible FXR activation experiments with Tropifexor (LJN452), from sub-nanomolar receptor engagement to intestinal barrier, metabolic, and liver-model readouts. This workflow emphasizes solvent control, time-course design, orthogonal validation, and careful separation of FXR-specific conclusions from broader anti-fibrotic observations.

• Mubritinib–HSA Recognition: Methods and Implications

  2026-09-16

  The 2023 Molecular Pharmaceutics study combines fluorescence spectroscopy, biochemical assays, and molecular docking to define how mubritinib recognizes human serum albumin (HSA). Its findings connect site I binding and static fluorescence quenching with modest structural remodeling and competitive inhibition of HSA esterase-like activity, providing a mechanistic basis for interpreting mubritinib distribution and protein-mediated pharmacological effects.

• Angiotensin III Workflow for RAAS Research

  2026-09-16

  Build reproducible RAAS, receptor-signaling, and neuroendocrine assays around Angiotensin III (human, mouse), with practical guidance for reconstitution, controls, and response interpretation. A reference-linked workflow also shows how this pressor activity mediator can be evaluated in spike–receptor binding assays without overstating early translational evidence.

• Renal K⁺ Channels and Perfusion in Sepsis

  2026-09-15

  This study distinguished ex vivo renal vascular reactivity from in vivo renal blood-flow responses in septic rats, showing that potassium-channel blockade can worsen pressor-associated hypoperfusion. Its main contribution is a subtype-sensitive interpretation of Kir6.1 and KCa1.1 signaling in the septic renal circulation, with direct implications for experimental vascular pharmacology.

• (S)-(+)-Ibuprofen COX Inhibitor Workflows

  2026-09-15

  Build reproducible inflammation, pain, and environmental toxicity assays around the pharmacologically active ibuprofen enantiomer. This guide combines COX-focused dose design with practical solvent, controls, exposure, and troubleshooting strategies.

• Ibuprofen Toxicology and Biodegradation: Study Insights

  2026-09-14

  The 2023 Molecules review frames ibuprofen as an emerging contaminant by connecting high consumption, environmental release, persistence, and biological damage across aquatic and terrestrial systems. Its main practical contribution is a research agenda that evaluates bacterial biodegradation alongside improved monitoring and toxicity assessment rather than treating pharmaceutical pollution as a conventional wastewater problem.

• Geneticin, G-418 Sulfate: Selection Guide

  2026-09-14

  Geneticin, G-418 Sulfate provides selective pressure for cells expressing the neomycin resistance gene and can support cell-based antiviral assay development. Use the supplied concentration range and DENV-2 result as product-specific starting information, not as a universal dose for every cell line, virus, or experimental endpoint.

• Pollen Interference in EEM Hazard Classification

  2026-09-13

  Zhang et al. developed a fluorescence-data workflow that combines spectral preprocessing, feature transformation, and random forest classification to reduce pollen interference in hazardous bioaerosol identification. Fast Fourier transform processing increased reported classification accuracy to 89.24%, supporting more reliable discrimination of bacterial and toxin-related samples in excitation–emission matrix datasets.

• (S)-(+)-Ibuprofen: COX Inhibitor Workflows

  2026-09-12

  Build reproducible COX inhibition, inflammation pathway research, and environmental fate assays around the active ibuprofen enantiomer. This practical guide pairs dose-ranging, stereochemistry-aware controls, and degradation monitoring with troubleshooting for solubility, vehicle effects, and nominal-versus-measured exposure.

• ISRIB (trans-isomer) for ER Stress Research

  2026-09-11

  ISRIB (trans-isomer) provides a practical way to uncouple ISR-driven translation loss from upstream stress signaling in cell and tissue models. This guide connects PERK–eIF2α–ATF4 biology with hepatic stellate-cell fibrosis assays, apoptosis workflows, and carefully controlled neurobiology experiments.

• β-Elemene: From AMPK Signal to Assay Design

  2026-09-11

  β-Elemene research is moving beyond descriptive cytotoxicity toward pathway-aware assay design. This article interprets recent adipogenesis findings, clarifies AMPK evidence, and connects chemical handling with reproducible metabolic, apoptotic, and neuroprotection studies.

• Atropo-Enantioselective Suzuki Synthesis of Antimitotic Biar

  2026-09-10

  The reference study established a catalytic asymmetric route to an axially chiral biaryl related to the antimitotic natural product rhazinilam. Its key advance was an intermolecular Suzuki coupling controlled by a chiral binaphthyl ligand, delivering the nonbridged precursor of the biologically relevant atropisomer with up to 40% enantiomeric excess.

8567 records 1/572 page Next 12345 下5页 Last page